Progesterone and human placental lactogen inhibit leptin secretion on cultured trophoblast cells from human placentas at term.
The placenta is an important source of leptin production that contributes to the state of hyperleptinemia observed in pregnant women. Moreover, the synthesis of leptin and its receptors by syncytiotrophoblast cells suggests a potential paracrine or autocrine action of leptin in the placenta. In the present study we examined the effect of gestational hormones, human chorionic gonadotropin (hCG), human placental lactogen (hPL), progesterone and estradiol, on in vitro leptin release by human term trophoblast cells in culture. Placentas at term were obtained immediately after delivery from mothers with uncomplicated pregnancies. Leptin levels were measured by enzyme-linked immunosorbent assay in culture media of trophoblasts maintained in monolayer culture for 24, 48 and 72 h with different hormonal treatments or placebo. Treatment with hPL and progesterone led to a time- and dose-dependent decrease in leptin release that was statistically significant after 24 h, with a maximal effect after 72 h of incubation. In contrast, incubation with estradiol and hCG did not have exhibit any effect on leptin secretion at any of the doses and times assayed in this work. The results obtained in this study support that leptin can be considered a gestational hormone implied in the endocrine function of the placenta and that its secretion is at least partially regulated by steroid and peptidic reproductive hormones in trophoblast cells in vitro.
Coya
Raquel
R
Section of Pediatric Endocrinology, Hospital de Cruces, Barakaldo, Bizkaia, Spain. hegazkin@euskalnet.net
Martul
Pedro
P
Algorta
Jaime
J
Aniel-Quiroga
Ma Angeles
MA
Busturia
Ma Angeles
MA
Señarís
Rosa
R
D002478:Cells, Cultured; D006063:Chorionic Gonadotropin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004797:Enzyme-Linked Immunosorbent Assay; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D006801:Humans; D020738:Leptin / Q000032:analysis / Q000378:metabolism*; D010920:Placenta / Q000187:drug effects*; D010928:Placental Lactogen / Q000494:pharmacology*; D011247:Pregnancy; D011374:Progesterone / Q000494:pharmacology*; D013997:Time Factors; D014327:Trophoblasts / Q000187:drug effects* / Q000378:metabolism*
D006063:Chorionic Gonadotropin; D020738:Leptin; D011374:Progesterone; D004958:Estradiol; D010928:Placental Lactogen